Nosocomial bloodstream infections in United States hospitals: a three-year analysis
- PMID: 10476719
- DOI: 10.1086/520192
Nosocomial bloodstream infections in United States hospitals: a three-year analysis
Abstract
Nosocomial bloodstream infections are important causes of morbidity and mortality. In this study, concurrent surveillance for nosocomial bloodstream infections at 49 hospitals over a 3-year period detected >10,000 infections. Gram-positive organisms accounted for 64% of cases, gram-negative organisms accounted for 27%, and 8% were caused by fungi. The most common organisms were coagulase-negative staphylococci (32%), Staphylococcus aureus (16%), and enterococci (11%). Enterobacter, Serratia, coagulase-negative staphylococci, and Candida were more likely to cause infections in patients in critical care units. In patients with neutropenia, viridans streptococci were significantly more common. Coagulase-negative staphylococci were the most common pathogens on all clinical services except obstetrics, where Escherichia coli was most common. Methicillin resistance was detected in 29% of S. aureus isolates and 80% of coagulase-negative staphylococci. Vancomycin resistance in enterococci was species-dependent--3% of Enterococcus faecalis strains and 50% of Enterococcus faecium isolates displayed resistance. These data may allow clinicians to better target empirical therapy for hospital-acquired cases of bacteremia.
Comment in
-
Nosocomial bloodstream infections: are positive blood cultures misleading?Clin Infect Dis. 2000 Jun;30(6):986. doi: 10.1086/313835. Clin Infect Dis. 2000. PMID: 10880328 No abstract available.
-
Estimating the cost of nosocomial candidemia in the united states.Clin Infect Dis. 2001 Apr 1;32(7):1110. doi: 10.1086/319613. Clin Infect Dis. 2001. PMID: 11264044 No abstract available.
Similar articles
-
Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities.Pediatr Infect Dis J. 2003 Aug;22(8):686-91. doi: 10.1097/01.inf.0000078159.53132.40. Pediatr Infect Dis J. 2003. PMID: 12913767
-
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.Clin Infect Dis. 2004 Aug 1;39(3):309-17. doi: 10.1086/421946. Epub 2004 Jul 15. Clin Infect Dis. 2004. PMID: 15306996
-
Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.J Microbiol Immunol Infect. 2006 Apr;39(2):135-43. J Microbiol Immunol Infect. 2006. PMID: 16604246
-
Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature.Diagn Microbiol Infect Dis. 2007 Dec;59(4):401-6. doi: 10.1016/j.diagmicrobio.2007.07.001. Epub 2007 Sep 20. Diagn Microbiol Infect Dis. 2007. PMID: 17888612 Review.
-
Nosocomial bloodstream infections: organisms, risk factors, and implications.Clin Infect Dis. 2000 Sep;31 Suppl 4:S139-43. doi: 10.1086/314078. Clin Infect Dis. 2000. PMID: 11017863 Review.
Cited by
-
The clinical outcomes and predictive factors for in-hospital mortality in non-neutropenic patients with candidemia.Medicine (Baltimore). 2016 Jun;95(23):e3834. doi: 10.1097/MD.0000000000003834. Medicine (Baltimore). 2016. PMID: 27281087 Free PMC article.
-
In vivo inhibitory effect on the biofilm formation of Candida albicans by liverwort derived riccardin D.PLoS One. 2012;7(4):e35543. doi: 10.1371/journal.pone.0035543. Epub 2012 Apr 24. PLoS One. 2012. PMID: 22545115 Free PMC article.
-
Use of the PATH Alliance database to measure adherence to IDSA guidelines for the therapy of candidemia.Eur J Clin Microbiol Infect Dis. 2007 Dec;26(12):907-14. doi: 10.1007/s10096-007-0383-4. Eur J Clin Microbiol Infect Dis. 2007. PMID: 17899230
-
mecA-blaZ corepressors in clinical Staphylococcus aureus isolates.Antimicrob Agents Chemother. 2003 Apr;47(4):1460-3. doi: 10.1128/AAC.47.4.1460-1463.2003. Antimicrob Agents Chemother. 2003. PMID: 12654694 Free PMC article.
-
Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.Antimicrob Agents Chemother. 2005 May;49(5):2084-92. doi: 10.1128/AAC.49.5.2084-2092.2005. Antimicrob Agents Chemother. 2005. PMID: 15855534 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources